← Back to Search

Family Peer Navigator for Early Psychosis

N/A

Recruiting

Research Sponsored by Washington State University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

≥ 18 years of age

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

Awards & highlights

Study Summary

This trial will develop, refine, and pilot-test a multi-component Family Peer Navigator model designed to increase access to and initial engagement in coordinated specialty care for early psychosis among Black/African American families.

Who is the study for?

This trial is for Black/African American adults over 18 with a family member at risk of psychosis, indicated by a score of ≥3 on the Prodromal Questionnaire-Brief Version. Participants must speak English and be able to understand the consent process. Those already eligible for coordinated specialty care are excluded.Check my eligibility

What is being tested?

The study is testing a Family Peer Navigator model designed to help Black families access and engage in early psychosis care. It involves developing, refining, and pilot-testing this multi-component approach through mixed methods research.See study design

What are the potential side effects?

Since this trial focuses on a service intervention rather than medication, traditional side effects are not applicable. However, participants may experience emotional or psychological impacts from discussing mental health issues.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and months 1 through 3 of treatment period; repeated measure to assess change in acceptability through study completion, average of 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Client Satisfaction Questionnaire-8 (CSQ-8)

Level of Engagement to measure feasibility

Number of Referrals (Recruitment) to assess feasibility

+2 more

Secondary outcome measures

Culturally-adapted Knowledge about Psychosis questionnaire (CaKAP)

General Self-Efficacy scale

Scale to Assess Therapeutic Relationships in Community Mental Health Care (STAR)

+2 more

Other outcome measures

Adherence to model

Initial Engagement to assess preliminary effectiveness

Time from Referral to Enrollment to assess

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Family Peer Navigator model Psychosis Phase IIIExperimental Treatment1 Intervention

Family member participants randomized to the Family Peer Navigator condition will participate in two sessions for introduction/assessment, four individual psychoeducation sessions, and six brief check ins delivered by Family Peer Navigators.

Group II: Care Coordination Phase IIIActive Control1 Intervention

Family member participants randomized to the active control will receive two brief psychoeducation sessions, two brief check ins across one month and linked to appropriate services.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

Washington State UniversityLead Sponsor

101 Previous Clinical Trials

56,664 Total Patients Enrolled

National Institute of Mental Health (NIMH)NIH

2,784 Previous Clinical Trials

2,689,225 Total Patients Enrolled

1 Trials studying Family

220 Patients Enrolled for Family

Media Library

Family Peer Navigator for Early Psychosis Clinical Trial Eligibility Overview. Trial Name: NCT05284721 — N/A

Family Research Study Groups: Care Coordination Phase III, Family Peer Navigator model Psychosis Phase III

Family Clinical Trial 2023: Family Peer Navigator for Early Psychosis Highlights & Side Effects. Trial Name: NCT05284721 — N/A

Family Peer Navigator for Early Psychosis 2023 Treatment Timeline for Medical Study. Trial Name: NCT05284721 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies remaining in this clinical experiment?

"According to clinicaltrials.gov, the recruitment phase of this particular medical trial has concluded; it was initially posted on October 1st 2022 and recently updated March 8th 2022. However, 15 other trials are actively recruiting participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Family Peer Navigator for Early Psychosis for Black Families

Oladunni Oluwoye 2023. "Family Peer Navigator for Early Psychosis for Black Families". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05284721.